AIMI - AIM ImmunoTech Inc.
10.15
0.650 6.404%
Share volume: 97,105
Last Updated: 06-17-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.50
0.65
0.07%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2025 | 08-14-2025 | 11-17-2025 | |
| Cash flow financing | 660.000 K | 355.000 K | 6.654 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -803.000 K | -422.000 K | 1.871 M | |
| Net income | -3.705 M | -2.794 M | -3.284 M | |
| Depreciation | 10.000 K | 9.000 K | 9.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 19.000 K | 0.000 | 0.000 | |
| Investing Cashflow | 898.000 K | 754.000 K | 296.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | -803.000 K | -422.000 K | 1.871 M |